<DOC>
	<DOCNO>NCT01130961</DOCNO>
	<brief_summary>The purpose study determine progression-free survival lung cancer patient receive gefitinib clinical practice Thailand .</brief_summary>
	<brief_title>Management Advanced Non-Small Cell Lung Cancer ( NSCLC ) Clinical Outcomes Patients Who Received Gefitinib Thailand</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<criteria>Diagnosed lung cancer base histological/cytological finding Admitted hospital January 2004 December 2008 Treated gefitinib least 3 month Involvement plan and/or conduct study Participation another clinical study last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Advanced NSCLC</keyword>
	<keyword>Gefitinib</keyword>
	<keyword>Thai patient</keyword>
</DOC>